Норвегия -
норвежский -
Statens legemiddelverk
biphozyl
baxter holding b.v. - magnesiumkloridheksahydrat / natriumklorid / kaliumklorid / dinatriumfosfatdihydrat / natriumhydrogenkarbonat - hemodialyse-/hemofiltreringsvæske
Норвегия -
норвежский -
Statens legemiddelverk
phoxilium 1,2 mmol/l fosfat
baxter holding b.v. - kalsiumkloriddihydrat / dinatriumfosfatdihydrat / magnesiumkloridheksahydrat / natriumklorid / natriumhydrogenkarbonat / kaliumklorid - hemodialyse-/hemofiltreringsvæske
Норвегия -
норвежский -
Statens legemiddelverk
dexadreson vet 2 mg/ ml
intervet international bv - 5831 an - deksametasonnatriumfosfat - injeksjonsvæske, oppløsning - 2 mg/ ml
Норвегия -
норвежский -
Statens legemiddelverk
monopex 1 mg/ ml
laboratoires théa s.a.s - deksametasonnatriumfosfat - Øyedråper, oppløsning i endosebeholder - 1 mg/ ml
Норвегия -
норвежский -
Statens legemiddelverk
spersadex 1 mg/ ml
blumont ofta trading limited - deksametasonnatriumfosfat - Øyedråper, oppløsning - 1 mg/ ml
Норвегия -
норвежский -
Statens legemiddelverk
dexavit 4 mg/ ml
vital pharma nordic aps - deksametasonnatriumfosfat - injeksjons-/infusjonsvæske, oppløsning - 4 mg/ ml
Норвегия -
норвежский -
Statens legemiddelverk
dexacur 4 mg/ ml
abboxia ab - deksametasonnatriumfosfat - injeksjons-/infusjonsvæske, oppløsning - 4 mg/ ml
Норвегия -
норвежский -
Statens legemiddelverk
alfadexx vet 2 mg/ ml
alfasan nederland b.v. - deksametasonnatriumfosfat - injeksjonsvæske, oppløsning - 2 mg/ ml
Норвегия -
норвежский -
Statens legemiddelverk
technescan hdp -
curium netherlands b.v. - natriumoksidronat - preparasjonssett til radioaktive legemidler
Европейский союз -
норвежский -
EMA (European Medicines Agency)
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiske midler - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.